| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |